IRIDEX announces launch of a Modular Multi-Wavelength laser photocoagulator solution

IRIDEX Corporation (Nasdaq: IRIX) today announced the introduction of a Modular Multi-Wavelength laser photocoagulator solution, which will be featured at the 2009 American Academy of Ophthalmology meeting in San Francisco.

"Our new Modular Multi-Wavelength solution allows us to compete in the multi-wavelength photocoagulator market segment with a flexible, reliable, and cost-effective solid-state system," commented Theodore A. Boutacoff, President & CEO. "Multi-wavelength laser systems are typically used in the office or clinic by ophthalmologists who specialize in treating the retina. Our offering uses two wavelengths: yellow (577) and infrared (810). Combining the preferred clinical capability of our high powered IQ 577 yellow laser with the flexibility of our IQ 810 and OcuLight SLx infrared lasers increases the physician's treatment options beyond a traditional multi-wavelength system while presenting a more economical solution. Traditional multi-wavelength laser systems include both a yellow and a green laser because the traditional yellow laser lacks sufficient power to perform all typical visible wavelength laser photocoagulation procedures. Our new offering is a full-featured, technically advanced, multi-wavelength solution with the added advantage of a modular design."

Both yellow and infrared laser modules can be purchased as separate standalone lasers and then, at any time, can be combined with an IRIDEX Symphony 2 Slit Lamp Adapter to create a multi-wavelength system tailored to meet the customer's specific needs.